Cost Effectiveness of Cetuximab and Panitumumab for First-Line RAS WT Metastatic Colorecal Cancer
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1612
https://www.valueinhealthjournal.com/article/S1098-3015(16)01680-6/fulltext
Title :
Cost Effectiveness of Cetuximab and Panitumumab for First-Line RAS WT Metastatic Colorecal Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01680-6&doi=10.1016/j.jval.2016.03.1612
First page :
A154
Section Title :
Cancer - Cost Studies
Open access? :
No
Section Order :
334